10/10/22 General Evgen licenses the global rights for lead asset SFX‐01 in neurodevelopmental disorders and schi...
28/09/22 General PharmaVentures’ new Vice President recruited to lead Pricing and Market Access practice
26/09/22 General Oxford Cancer Biomarkers announces European expansion of life-saving chemotherapy toxicity test...